1,354,617 research outputs found
Principi di storia e cultura ebraica
No full textPrincipi di storia e cultura ebraica / Emanuele Artom ; con prefazione di Max Varadi - 3 ed. / aggiornata da Menachem Emanuele Artom - Roma : Fondazione Per La Gioventù Ebraica, 1957 (Tip. Dapco, Daily American Publishing Co.) - 164 p. : ill. ; 24 c
Varadi Papp syndrome, an unusual variant of oral-facial-digital syndrome: Report of a rare case
No full textVaradi Papp syndrome or oral-facial-digital syndrome type VI (OFDS VI) is a rare autosomal-recessive disorder distinguished from other OFDSs by metacarpal abnormalities with central polydactyly and by cerebellar abnormalities. Our patient had a broad forehead, arched eyebrows, left-sided squint, hypertelorism, epicanthic folds, fleshy nodular tongue, midline upper lip cleft, high arched palate, both pre-axial and post-axial polydactyly of limbs, hypotonia and cerebellar hypoplasia with molar tooth sign consistent with the diagnosis of Varadi Papp syndrome
Comparative effect of composite management of type II diabetes mellitus with induced emesis and Varadi Ghanavati: A pilot clinical study
No full textIntroduction: Ayurveda offers a rational view in the management of Prameha. Shodhana (∼bio-purification) is advocated as the first line of treatment to eliminate Kapha, which is followed by palliative treatment to further control disease pathology. Evaluation of such composite treatment has rarely been published. The present study was conducted to assess the comparative efficacy and safety of three interventions in the management of Prameha (Diabetes mellitus type II (T2DM)) - (a) Vamana (induced emesis) and Varadi Ghanavati (oral Ayurvedic medication), (b) Varadi Ghanavati, and (c) glibenclamide. Methods: It was open labelled, comparative, randomised, prospective, three arm pilot study. A total 49 patients, newly diagnosed or known cases of Prameha (T2DM) were randomised in three groups. The first group (Vamana) received Vamana followed by Varadi Ghanavati (500 mg (mg) thrice daily before food for 12 weeks). The second (Varadi) group received Varadi Ghanavati without prior Vamana, while, the control group received glibenclamide 5 mg twice daily before food for 12 weeks. Patients were evaluated at intervals of each four weeks. Assessment was done on changes seen in blood sugar (BSL) fasting (F), postprandial (PP), glycosylated haemoglobin, lipid profile, body mass index (BMI) and clinical symptoms. Results: Patients in all groups showed better glycaemic control as compared to baseline. Mean BSLF before and after treatment were 166.20 ± 78.39 mg/dL and 125.00 ± 58.77 mg/dL in Vamana group (p < 0.01), 163.60 ± 59.34 mg/dL and 127.73 ± 37.94 mg/dL in Varadi group (p < 0.05), while 163.00 ± 59.03 mg/dL and 129.40 ± 41.91 mg/dL in control (p < 0.05). Similarly, BSL PP values before and after treatment were 254.47 ± 99.59 mg/dL and 178.47 ± 68.45 mg/dL in Vamana group (p < 0.01), 233.93 ± 68.95 mg/dL and 185.20 ± 56.73 mg/dL in Varadi group (p < 0.05), 239.80 ± 77.10 mg/dL and 182.53 ± 42.14 mg/dL in control (p < 0.05). Glycosylated haemoglobin, mean values before and after treatment were 8.23 ± 1.71% and 7.18 ± 1.96% in Vamana group (p < 0.05), 7.83 ± 1.21% and 6.75 ± 1.13% in Varadi group (p < 0.05), 7.17 ± 1.12% and 6.60 ± 0.65% in glibenclamide group (p < 0.05). Comparative evaluation in the three groups showed that there was a statistically significant reduction (p < 0.001) in total cholesterol, low-density lipoproteins (LDL) and BMI in Vamana group as compared the other groups. No adverse event was observed. Conclusion: Along with better glycaemic control, composite treatment can reduce deranged lipids and BMI, which can help in better management of Prameha (T2DM). Vamana and Varadi Ghanavati can be administered safely.Clinical Trial Registration No.: CTRI/2017/10/010127
Going Beyond Counting First Authors in Author Co-citation Analysis
No full textThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Growth and nutritional trials on transgenic Nile tilapia containing an exogenous fish growth hormone gene
No full textIn a long-term growth trial, transgenic tilapia Oreochromis niloticus L. showed a 2·5-fold
increase in growth compared with non-transgenic siblings. At 7 months, mean mass of
transgenic tilapia was 653 g compared with 260 g for non-transgenic siblings. A significant
increase (P<0·01) in head : total length ratio, viscera-somatic index and hepato-somatic index
was observed in transgenic fish. Female gonado-somatic index (IG) was found to be lower in
transgenics than non-transgenic siblings in both mixed and separate culture conditions.
Transgenic male IG values were found to be higher in mixed culture and lower in separate
culture than that of their non-transgenic siblings. Food conversion efficiency was more than
20% greater in the transgenic fish. In a second shorter-term growth performance trial, the
transgenic fish grew to about four times the size of their non-transgenic siblings. A digestibility
trial suggested that transgenic tilapia were more efficient utilizers of protein, dry matter and
energy. Apparent digestibility of protein and apparent energy digestibility were higher in the
transgenic fish
Variations on the Author
No full text“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
No full textWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Imaging Ca2+ concentration changes in the matrix of secretory vesicles in insulin secreting cells
No full textOvde. Mnogoglasje Banata u dokumentarnoj prozi Tibora Varadija
No full textDokumentarna proza Tibora Varadija posvećena je slučajevima iz advokatske prakse Kancelarije Varadi, koja je delovala više od jednog stoleća – od 1893. do 2014. godine – u Zrenjaninu/Bečkereku i sačuvala bogatu advokatsku arhivu. Na početku ovog poglavlja se daju podazi iz biografije Tibora Varadija, a drugi deo čini razgovor s autorom o njegovim knjigama, uz kritičko preispitivanje društvenih pojmova, kao što su značaj arhiva, iskustvo života u graničnim oblastima, kulturno pamćenje, značaj prava i pravednosti, mešoviti brakovi, višejezičnost, značaj svakodnevice, odnos prema fašizmu i komunizmu, pitanje izvesnosti identiteta, i dr. Zasnovan na primerima iz Varadijeve proze, intervju pokušava da odgovori na pitanje u kojoj meri se uočava (dis)kontinuitet s praksama višejezičnosti iz prošlosti i kako su određeni istorijski događaji oblikovali živote manjina i upotrebu jezika u Vojvodini.Tibor Várady’s documentary prose is based on the court cases from the Várady Law Office, which worked for more than a century – from 1893 to 2014 – in Zrenjanin/Nagybecskerek and has preserved a rich archive. The first part of the chapter is dedicated to the biography of Tibor Várady, and the second part is an interview with the author about his books, with a critical review of social concepts, such as the importance of archives, the experience of life in border areas, cultural memory, the importance of law and justice, mixed marriages, multilingualism, everyday life, attitude towards fascism and communism refracted through court archives, certainty of identity, etc. Based on the Várady’s prose, the interview attempts to answer to what extent there is a (dis)continuity with the practices of multilingualism from the past and how certain historical events shaped the lives of minorities and language use in Vojvodina
- …
